1. Use of Normotest and Thrombotest, coagulation tests in hepatocellular In our study, a relation between antithrombin III disease;Hillenbrand, P.; Sherlock, S.;Scand J Gastroenterol; and fibrinogen concentration was observed. 125-31. Most of the patients with a low fibrinogen concentration had a low antithrombin III value and the majority of the patients with a normal antithrombin III value had a normal fibrinogen concentration. Nevertheless, one third of the patients with a normal fibrinogen value exhibition an abnormal value of antithrombin III and most of
2. Observations of increased levels of blood coagulation factors and other plasma proteins in cholestatic liver disease;Cederblad, G.;Scand J Gastroenterol,1976
3. Metabolism of fibrinogen in cirrhosis of the liver;Tytgat, G.; Collen, D.; Verstraete, M.;J Clin Invest,1971
4. these patients presented an abnormality of Parbhoo SP, Sherlock S. Fibrinolysis in cholestatic Thrombotest. Aurousseau has previously shown a jaundice;Jedrychowski, A.; Hillenbrand, P.; Ajdukiewicz, A.B.;Br Med J; 1: 640-2. close correlation between plasma antithrombin III and prothrombin concentrations in patients with liver cirrhosis." These observations suggested that antithrombin III values were abnormal in both severe hepatic failure (with low fibrinogen concentrations) and in moderate liver insufficiency (with normal fibrinogen concentrations and,1973
5. Antithrombin III in rat hepatocytes;Leon, M.; Aiach, M.; Guennec, J.Y.; Jarnet, J.; Girot, R.; Fiessinger, J.N.; Jaubert, F.;Thromb Res,1982